ARCHIVES

ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

Bill Pressures HCFA To Launch Project On Reimbursement for Cancer Trials

July 26, 1996

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

MD Anderson’s Balance Sheet is Issue No. 1 For DePinho’s “Moon Shots Program”

October 12, 2012

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011